Keybank National Association Apellis Pharmaceuticals, Inc. Call Options Transaction History
Keybank National Association
- $24.1 Billion
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding APLS
# of Institutions
298Shares Held
113MCall Options Held
5.21MPut Options Held
691K-
Wellington Management Group LLP Boston, MA16.4MShares$653 Million0.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$463 Million15.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$443 Million5.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$391 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$231 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $4.38B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...